A systematic review of adverse events of rifapentine and isoniazid compared to other treatments for latent tuberculosis infection

MLA

Brian Hutton, et al. “A Systematic Review of Adverse Events of Rifapentine and Isoniazid Compared to Other Treatments for Latent Tuberculosis Infection.” Pharmacoepidemiology and Drug Safety, vol. 27, Mar. 2018, pp. 557–66. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....748d90a4d9e3cab294968fbe543690d9&authtype=sso&custid=ns315887.

APA

Brian Hutton, Dianna Wolfe, Fatemeh Yazdi, Gonzalo G. Alvarez, Pauline Barbeau, Christopher Pease, Becky Skidmore, & Candyce Hamel. (2018). A systematic review of adverse events of rifapentine and isoniazid compared to other treatments for latent tuberculosis infection. Pharmacoepidemiology and Drug Safety, 27, 557–566.

Chicago

Brian Hutton, Dianna Wolfe, Fatemeh Yazdi, Gonzalo G. Alvarez, Pauline Barbeau, Christopher Pease, Becky Skidmore, and Candyce Hamel. 2018. “A Systematic Review of Adverse Events of Rifapentine and Isoniazid Compared to Other Treatments for Latent Tuberculosis Infection.” Pharmacoepidemiology and Drug Safety 27 (March): 557–66. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....748d90a4d9e3cab294968fbe543690d9&authtype=sso&custid=ns315887.